Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma. This evidence concerns the gene ALB and renal pelvis/ureter urothelial carcinoma.